Methylation profiling

Dataset Information

0

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma


ABSTRACT: DNA methylation at the 5-position of cytosine (5-mC) is a key epigenetic mark critical for varius biological and pathological processes. 5-mC can be converted to 5-hydroxymethylcytosine (5-hmC) by the Ten-Eleven Translocation (TET) family of DNA hydroxylases. Here we report that "loss of 5-hmC" is an epigenetic hallmark of melanoma with diagonostic and prognostic implications. Genome-wide mapping of 5-hmC in nevi and melanomas for the first time revealed loss of 5-hmC landscape in the melanoma epigenome. Downregulation of Isocitrate Dehydrogenase 2 (IDH2) and TET family enzymes proved to be one of the mechanisms underlying the loss of 5-hmC during melanoma development, and rebuilding the 5-hmC landscape in the melanoma epigenome by reintroducing active TET2 or IDH2 suppressed melanoma growth and increased tumor-free survival. Thus, our study establishes that "loss of 5-hmC" is a new epigenetic hallmark of melanoma and links IDH and TET family enzymes-mediated 5-hmC putative tumor suppressor pathway to the suppression of melanoma progression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE38231 | GEO | 2012/09/18

SECONDARY ACCESSION(S): PRJNA167460

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-09-18 | E-GEOD-38231 | biostudies-arrayexpress
2021-09-23 | GSE167949 | GEO
2019-01-23 | GSE113386 | GEO
2018-04-11 | GSE108872 | GEO
2013-06-30 | E-GEOD-46402 | biostudies-arrayexpress
2013-02-26 | PXD000143 | Pride
2013-06-30 | GSE46402 | GEO
2013-06-30 | GSE46319 | GEO
2019-10-09 | GSE138597 | GEO
2013-06-30 | E-GEOD-46319 | biostudies-arrayexpress